Completed OBSERVATIONAL NCT04530240

Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy

Impact of National MELD ≥ 30 Priority Allocation System on Dropout and Post-Transplant Survival Rates in Italy: A Retrospective Competing-Risk Analysis

Sponsor: A.O.U. Città della Salute e della Scienza

Conditions HCC Liver Transplant Disorder

Interventions Liver Transplantation

Updated 5 times since 2020 Last updated: Aug 24, 2020 Started: Aug 1, 2010 Primary completion: Aug 31, 2018 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates HCC and Liver Transplant Disorder and is currently completed. A.O.U. Città della Salute e della Scienza leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Aug 2024 — Sep 2024 [monthly]

Completed
Jul 2024 — Aug 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Sep 2020 — Jan 2021 [monthly]

Completed

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

A.O.U. Città della Salute e della Scienza
Catholic University of the Sacred Heart
Niguarda Hospital
University of Bologna
University of Pisa
University of Roma La Sapienza

Data source: University of Bologna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.